- Author:
Jun-Peng LONG
1
;
Yang SUN
1
;
Jiao YAO
1
;
Song-Wei YANG
1
;
Yan-Tao YANG
1
;
Gang PEI
1
;
Qi-Di AI
1
;
Nai-Hong CHEN
1
;
Jun-Peng LONG
2
;
Yang SUN
2
;
Jiao YAO
2
;
Song-Wei YANG
2
;
Yan-Tao YANG
2
;
Gang PEI
2
;
Qi-Di AI
2
;
Nai-Hong CHEN
2
;
Sha-Sha LIU
3
;
Nai-Hong CHEN
4
Author Information
- Publication Type:Journal Article
- Keywords: Alzheimer's disease; cerebral ischemia; dihydromyricetin; neuroprotection; research progress
- From: Chinese Pharmacological Bulletin 2023;39(8):1422-1425
- CountryChina
- Language:Chinese
- Abstract: Dihydromyricetin is a dihydroflavone compound which widely exists in ampelopsis of grapevine family. It has many pharmacological effects, such as anti-inflammatory, antibacterial, anti-tumor, antioxidant, regulating blood glucose, reducing blood lipid, liver protection and so on. In recent years, it has been found that dihydromyricetin has a good neuroprotective effect and can play a certain pharmacological role in a variety of neurological diseases, including Alzheimer' s disease, depression, Parkinson's disease and stroke. The purpose of this paper is to review the research on the neuroprotective effect of dihydromyricetin in the past decade.